Media Coverage

Home / About Us / News Center / Media Coverage
  • Reset
142 Results


Building a Pipeline of Therapies to Treat Rare Mineralization Disorders

Global Genes spoke to the co-founder of Inozyme about ENPP1 deficiency, its lead experimental therapy to treat the condition, and its work with Rady Children’s Institute for Genomic Medicine to improve the diagnosis of newborns.

September 23, 2022

BeginNGS Program Seeks to Improve Pediatric Rare Disease Dx, Treatment via Rapid NGS, Data Curation


GENOMEWEB:In a paper published this week in the American Journal of Human Genetics, collaborators led by the Rady Children’s Institute for Genomic Medicine (RCIGM) formally spelled out plans to improve detection and treatment of rare hereditary pediatric diseases through rapid whole-genome sequencing (rWGS).

August 25, 2022

From Guthrie to Genomes: The Continued Evolution of Newborn Screening

CDC Genomics & Precision Health Blog

The CDC Genomics & Precision Health blog reviews the state of newborn screening today, including the BeginNGS program.

August 22, 2022

Advancing Newborn Screening For Rare Genetic Diseases

EP Magazine

EP Magazine: Researchers, industry, and patient advocacy groups are driving efforts to facilitate early diagnosis and improve babies’ long-term outlook. Commentary by Catherine Nester, BSN, Inozyme’s VP of Physician and Patient Strategies. 

August 10, 2022

Clinical Decision Support Tool Provides Effective Precision Medicine Guidance

Health IT Analytics

A study published this week in Nature Communications shows that an automated clinical decision support tool for genetic disease diagnosis and treatment can provide accurate results and disease management guidance within 13.5 hours.

July 28, 2022

​​Genomics is racing toward a $100 genome. Are we ready for it?


STAT: The ever-lower cost is helping to drive fast-moving changes in sequencing. Health systems are preparing to test programs that could lead to the use of whole-genome screening in millions of newborns.

July 27, 2022

Automated Genome-to-Treatment System Could Help Manage Genetic Disease

Inside Precision Medicine

INSIDE PRECISION MEDICINE: The results of an RCIGM research project show that an automated, virtual disease management system that includes fast whole genome sequencing and analysis could help to manage genetic diseases better.

July 26, 2022

The earlier the better: New consortium leverages infant screening to accelerate treatment


PHARMAVOICE: Newborn screening is gaining prominence across the biopharma and healthcare industries amid efforts to detect and treat disease as early as possible.

July 25, 2022

Rady Children’s Institute for Genomic Medicine Partners With Inozyme Pharma on NGS Newborn Screening


Inozyme Pharma said on Thursday that it has partnered with the Rady Children’s Institute for Genomic Medicine (RCIGM) on whole-genome sequencing-based newborn screening for genetic diseases. Through the BeginNGS consortium, the partners will use whole-genome sequencing-based newborn screening to identify infants affected by ENPP1 deficiency and ABCC6 deficiency. Inozyme is developing a novel therapy, INZ-701, currently in […]

June 16, 2022

Rady Children’s Institute launches newborn genetic disease screening

Rady Children’s Institute for Genomic Medicine (RCIGM) has launched a program that aims to advance newborn screening for treatable genetic diseases through rapid whole-genome sequencing.

June 15, 2022

Contact Us About BeginNGS